Megna Michael R sold KNSA
April 9, 2026 · Form 4 insider transaction
Megna Michael R sold 6,625 shares of Kiniksa Pharmaceuticals International, plc at $46.69 per share, a transaction worth $309.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,625
Price
$46.69
Total value
$309.3K
InsiderMegna Michael R
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateApril 9, 2026
Filing dateApril 13, 2026
Shares owned after27,418
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025.